Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $10.28 Analyst target: $25.25 Upside: 145.62%
Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company is headquartered in Celebration, Florida.
See the full interactive analysis & chart →Informational only — not investment advice.